Centria Cortisol Radioimmunoassay
by Union Carbide Corp. 510(k)
Active
510(k) K780725
Overview
The Centria Cortisol Radioimmunoassay is a diagnostic in vitro device classified as a radioimmunoassay for cortisol measurement. It employs radioisotope-based technology to quantify cortisol levels in serum or plasma samples, aiding in the assessment of adrenal function and endocrine disorders. This method relies on competitive binding between labeled and unlabeled cortisol to determine concentration through radioactive detection.
This device is supplied as a test kit for laboratory use, requiring specialized handling and compliance with radiation safety protocols. It is intended for single-use and must be stored under controlled conditions to maintain stability. The Centria Cortisol Radioimmunoassay holds FDA 510(k) clearance (K780725) and falls under the Clinical Chemistry advisory committee classification, adhering to regulatory standards for in vitro diagnostics. No information regarding MRI safety or reusable components is provided in the specifications.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK780725 | Date6 Jun 1978 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 5 Oct 2026.
Specification
- Full name
- Centria Cortisol Ria
- 510(k) Number
- FDA Product Code
- CGR
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1205
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent